Zofia Rodzewicz-Helias

Boulogne-billancourt, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Journal: Blood advances

Published: October 03, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Journal: Blood advances

Published: October 03, 2025

ALKATI Drives Nuclear Anaplastic Lymphoma Kinase (ALK) Expression in Histiocytic Neoplasms Without ALK Fusions.

ALKATI Drives Nuclear Anaplastic Lymphoma Kinase (ALK) Expression in Histiocytic Neoplasms Without ALK Fusions.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: August 08, 2025

TERT Promoter C228T and C250T Hotspot Mutations Are Absent in BRAF V600E-Positive Langerhans Cell Histiocytosis.

TERT Promoter C228T and C250T Hotspot Mutations Are Absent in BRAF V600E-Positive Langerhans Cell Histiocytosis.

Journal: Cancer medicine

Published: May 05, 2025

NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.

NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.

Journal: Blood advances

Published: February 10, 2025

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.

Journal: Blood advances

Published: October 30, 2024

Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads.

Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads.

Journal: Blood

Published: June 10, 2024

Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms.

Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms.

Journal: Blood advances

Published: May 02, 2024

Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions.

Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions.

Journal: Haematologica

Published: March 04, 2024

Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type.

Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type.

Journal: Blood advances

Published: August 09, 2023

OCT2 expression in histiocytoses.

OCT2 expression in histiocytoses.

Journal: Virchows Archiv : an international journal of pathology

Published: January 10, 2023

Molecular and clinicopathologic characterization of pediatric histiocytoses.

Molecular and clinicopathologic characterization of pediatric histiocytoses.

Journal: American journal of hematology

Published: January 06, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026